Synthesis, pro-apoptotic activity and 2D-QSAR studies of new analogues of fluphenazine. 2014

Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka

A series of 10 novel analogues of fluphenazine (FPh) were synthesized. Influence of the synthesized analogues of FPh on frequency of apoptosis and necrosis in cultures of human lymphocytes genotoxically damaged in vitro with benzo[a]pyrene (B[a]P; 7,5 microM, 48 h) was compared with the effect of FPh. Activity of the tested compounds was expressed by ED50 (pro-apoptotic activity) and TD50 (pro-necrotic effect, cytotoxicity). It was noticed that compounds 3-9 and 12 exerted a pro-apoptotic effect markedly stronger than that of FPh. Additionally, compounds 3, 9 and 10 exhibited the weakest influence on frequency of necrotic lymphocyte in cultures. 2D-QSAR analysis was done in order to find quantitative relationship between structures of the tested analogues and their pro-apoptotic activity or pro-necrotic effect in B[a]P-damaged cell cultures. Several statistically significant QSAR models were generated. Information obtained from 2D-QSAR study will be used in further design of analogues of FPh more active in cancer chemoprevention.

UI MeSH Term Description Entries
D008297 Male Males
D005476 Fluphenazine A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE. Flufenazin,Fluphenazine Hydrochloride,Lyogen,Prolixin,Hydrochloride, Fluphenazine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016588 Anticarcinogenic Agents Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. Anti-Carcinogenic Agents,Anti-Carcinogenic Drugs,Anti-Carcinogenic Effect,Anti-Carcinogenic Effects,Anticarcinogenic Drugs,Anticarcinogenic Effect,Anticarcinogenic Effects,Anticarcinogens,Agents, Anti-Carcinogenic,Agents, Anticarcinogenic,Anti Carcinogenic Agents,Anti Carcinogenic Drugs,Anti Carcinogenic Effect,Anti Carcinogenic Effects,Drugs, Anti-Carcinogenic,Drugs, Anticarcinogenic,Effect, Anti-Carcinogenic,Effect, Anticarcinogenic,Effects, Anti-Carcinogenic,Effects, Anticarcinogenic
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
January 2003, Cellular & molecular biology letters,
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
April 2019, Bioorganic chemistry,
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
August 2006, Bioorganic & medicinal chemistry,
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
July 2016, Molecules (Basel, Switzerland),
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
June 2016, Bioorganic chemistry,
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
October 2019, Bioorganic & medicinal chemistry,
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
January 2014, Chemical & pharmaceutical bulletin,
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
November 2017, European journal of medicinal chemistry,
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
July 2002, Bioorganic & medicinal chemistry,
Joanna Zyta, and Agata Jaszczyszyn, and Piotr Swiatek, and Kazimierz Gasiorowski, and Wiesław Malinka
January 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!